66
7
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9022 |
AZD9977
AZD 9977 |
Glucocorticoid Receptor | Endocrinology/Hormones |
AZD9977 是一种选择性的,有效的,具有口服活性的盐皮质激素受体 (MR) 调节剂,可用于研究心力衰竭和慢性肾病。 | |||
T1088 |
Repaglinide
AG-EE 388 ZW,AG-EE 623ZW,瑞格列奈 |
Potassium Channel; PPAR | DNA Damage/DNA Repair; Membrane transporter/Ion channel; Metabolism |
Repaglinide (AG-EE 623ZW) 是一种能够用于2 型糖尿病的胰岛素促分泌剂。 | |||
T1603 |
Glipizide
CP 28720,K 4024,格列吡嗪 |
Potassium Channel; PPAR; ABC | DNA Damage/DNA Repair; Membrane transporter/Ion channel; Metabolism |
Glipizide (CP 28720) 是一种有效的、具有口服活性的磺酰脲类抗糖尿病试剂 (anti-diabetic agent),在 2 型糖尿病的研究中具有价值,但不适用于1 型糖尿病。Glipizide 是通过部分阻断郎格汉斯胰岛细胞中 ATP 敏感钾通道 (KATP)发挥活性 。 | |||
T3104 |
Globalagliatin
LY2608204 |
Glucokinase | Metabolism |
Globalagliatin (LY2608204) 是一种葡萄糖激酶 (GK) 活化剂,EC50=42 nM。 | |||
T2385 |
Ipragliflozin
伊格列净,ASP1941 |
SGLT | GPCR/G Protein |
Ipragliflozin (ASP1941) 是一种口服有效的,选择性的 SGLT2抑制剂,对人 SGLT2 和 SGLT1,大鼠 SGLT2 和 SGLT1,小鼠 SGLT2 和 SGLT1 的 IC50分别为 7.38 和 1876 nM,6.73 和 1166 nM,5.64 和 1380 nM。Ipragliflozin 具有抗糖尿病活性。 | |||
T71394 |
BMS-823778
|
||
BMS-823778 is an orally available potent and selective inhibitor of 11-β-hydroxysteroid-dehydrogenase 1 (11βHSD-1). BMS-823778 is a potential therapeutic agent for type 2 diabetes mellitus (T2DM). | |||
T2316 |
Omarigliptin
MK-3102,奥格列汀 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Omarigliptin (MK-3102) 是高效选择性 DPP4抑制剂,IC50=为1.6nM。 | |||
TP1469 |
Lixisenatide acetate (320367-13-3 free base)
Lixisenatide acetate |
Glucagon Receptor | GPCR/G Protein |
Lixisenatide acetate 是一种胰高血糖素样肽 1 受体的激动剂,可用于研究 2 型糖尿病。 | |||
T2701 |
GSK1292263
|
GPR | Endocrinology/Hormones; GPCR/G Protein |
GSK1292263 是口服具有活性的 GPR119 激动剂,对人和大鼠 GPR119的pEC50分别为 6.9 和 6.7,它可用于研究 2 型糖尿病 (T2DM) 。 | |||
T6961 |
PX-478
PX-478 2HCl |
HIF/HIF Prolyl-Hydroxylase; HIF; Autophagy | Angiogenesis; Autophagy; Chromatin/Epigenetic; Metabolism |
PX-478 是一种 HIF-1α 抑制剂,具有选择性、口服活性和血脑屏障渗透性。PX-478 具有抗肿瘤活性,还可以保护糖尿病中的胰腺 β 细胞功能,用于 2 型糖尿病的研究。 | |||
TP1796 |
Albiglutide TFA (782500-75-8 free base)
Albiglutide TFA |
Glucagon Receptor | GPCR/G Protein |
Albiglutide TFA (782500-75-8 free base) (Albiglutide TFA) 是一种长效 GLP-1 受体激动剂,用于治疗 2 型糖尿病 (T2DM)。 | |||
T14130 |
Adomeglivant
LY2409021 |
Glucagon Receptor | GPCR/G Protein |
Adomeglivant (LY2409021) 是一种高效的选择性胰高血糖素受体 (GluR) 变构拮抗剂,主要用于2型糖尿病的研究。 | |||
T8780 |
AMG131
INT-131,AMG-131,CHS 131 |
PPAR | DNA Damage/DNA Repair; Metabolism |
AMG131 (CHS 131) 是一种新型非噻唑烷二酮(TZD) 选择性过氧化物酶体增殖物激活受体 (PPAR) γ 调节剂,可用于治疗 2 型糖尿病。 | |||
T27841 |
Lobeglitazone Sulfate
CKD501 Sulfate,CKD501,CKD-501 Sulfate,CKD 501 Sulfate,CKD 501,CKD-501,Lobeglitazone Sulfate. trade name Duvie, Chong Kun Dang |
NOD | Immunology/Inflammation; NF-κB |
Lobeglitazone Sulfate(CKD-501 Sulfate) 是一种新型噻唑烷二酮,具有抗炎活性,抑制LPS诱导的NLRP3炎症小体活化和肝脏炎症,可用于研究 2 型糖尿病 (T2DM)。 | |||
T15244 |
Ertugliflozin L-pyroglutamic acid
埃格列净,PF-04971729 L-pyroglutamic acid |
Others; SGLT | GPCR/G Protein; Others |
Ertugliflozin L-pyroglutamic acid (PF-04971729 L-pyroglutamic acid) 是一种特异性和口服活性的 hSGLT2 抑制剂,IC50 为 0.877 nM。 Ertugliflozin L-pyroglutamic acid 可用于治疗 2 型糖尿病的研究。 | |||
T7133 |
Anagliptin
SK-0403,阿拉格列汀 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Anagliptin (SK-0403) 是一种选择性的二肽酰肽酶 4 抑制剂,IC50=3.8 nM,对 DPP-8/9 的选择性相对较弱,IC50分别为 68 和 60 nM。 | |||
T16479 |
PF-04937319
|
Others; Glucokinase | Metabolism; Others |
PF-04937319 是一种葡萄糖激酶激活剂 (EC50 =154.4 μM)。 PF-04937319 保持降糖功效,同时降低许多其他 GKA 观察到的低血糖风险。 PF-04937319可用于治疗2型糖尿病的研究。 | |||
T14283 |
amyloid P-IN-1
|
Beta Amyloid | Neuroscience |
amyloid P-IN-1 可用于研究血清淀粉样蛋白 P 成分耗尽的疾病,例如阿尔茨海默病、淀粉样变性、骨关节炎和 2 型糖尿病。 | |||
T77781 |
Lotiglipron
PF-07081532 |
Glucagon Receptor | GPCR/G Protein |
Lotiglipron (PF-07081532) 是一种具有口服活性和有效性的 GLP-1R 激动剂,能够降低血糖和体重,可用于研究 2 型糖尿病 (T2DM) 和过度肥胖。 | |||
T36310 |
AKT-IN-6
INCB-047775 |
Akt | Cytoskeletal Signaling; PI3K/Akt/mTOR signaling |
AKT-IN-6 (INCB-047775)对ATK 有抑制作用。Akt 是对生长因子、细胞因子和其他细胞刺激的细胞信号传导的重要组成部分。Akt 的异常激活与2型糖尿病和癌症的发生密切相关。 | |||
T4460 |
Dapagliflozin ((2S)-1,2-propanediol, hydrate)
BMS-512148 (2S)-1,2-propanediol, hydrate,达格列净 (2S)-1,2-丙二醇水合物,Dapagliflozin propanediol monohydrate |
SGLT | GPCR/G Protein |
Dapagliflozin ((2S)-1,2-propanediol, hydrate) (BMS-512148 (2S)-1,2-propanediol, hydrate) 是 Dapagliflozin 1,2-propanediol, hydrate 的 S 型异构体,是竞争性葡萄糖协同转运蛋白2 抑制剂,可促进尿液中葡萄糖的排泄,可用于糖尿病的研究。它诱导 HIF1表达并减轻肾脏 IR 损伤。 | |||
T0242 |
Sitagliptin
西他列汀,MK0431,西格列汀 |
Proteasome; DPP-4; Autophagy | Autophagy; Proteases/Proteasome; Ubiquitination |
Sitagliptin (MK0431) 是一种有效的 DPP4抑制剂,在 Caco-2 细胞中,IC50值为 19 nM。它是一种新型口服降糖药,可单独使用或与二甲双胍或噻唑烷二酮联合用于治疗 2 型糖尿病。 | |||
T15810 |
LY2922470
|
GPR | Endocrinology/Hormones; GPCR/G Protein |
LY2922470 是选择性口服有效的GPR40激动剂,作用于 人 GPR40、小鼠 GPR40、大鼠 GPR40 的EC50值分别为 7 nM、1 nM、3 nM。它可降低血糖水平,同时显著增加胰岛素和 GLP-1,有潜力用于 2 型糖尿病的研究。 | |||
T11127 |
Dutogliptin tartrate
PHX-1149 |
Others | Others |
Dutogliptin tartrate is an effective and selective oral dipeptide-peptide-4 (DPP4) inhibitor for the treatment of type 2 diabetes mellitus. | |||
T30149 |
AS-1669058 oxalate
AS-1669058,AS 1669058,AS1669058 |
||
AS-1669058 is a G-protein-coupled receptor 119 (GPR119) agonist for the treatment of type 2 diabetes mellitus. | |||
T11128 |
Dutogliptin
PHX-1149 free base |
Others | Others |
Dutogliptin (PHX-1149 free base) is an oral, effective and selective dipeptide-peptide-4 (DPP4) inhibitor for the treatment of type 2 diabetes mellitus. | |||
T13022 | SSTR5 antagonist 2 | Others | Others |
SSTR5 antagonist 2 is a highly potent, oral active and selective antagonist of somatostatin (receptor) subtype 5 (SSTR5),with potential to treat type 2 diabetes mellitus (T2DM). | |||
T68500 | AZD-2207 | ||
AZD-2207 is a cannabinoid receptor CB1 antagonist and highly lipophilic compound for the treatment of type 2 diabetes mellitus and obesity. | |||
T24422 |
LY3104607
LY 3104607,LY-3104607 |
||
LY3104607 is a G Protein-Coupled Receptor 40 agonist. It is active in oral treatment for patients with type 2 diabetes mellitus and is a glucose-lowering drug candidate. | |||
T71181 | GSK256073 Tris | ||
GSK256073 is an agonist of G-protein coupled receptor 109A (GPR109A). It acts by reducing serum glucose in subjects with type 2 diabetes mellitus. | |||
T40374 |
Pal-Glu(OSu)-OH
|
||
Pal-Glu(OSu)-OH is a side chain specific to Liraglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist employed in type 2 diabetes mellitus research. | |||
T19548 |
Repaglinide D5
AG-EE 623ZW D5,瑞格列奈 D5 |
Others | Others |
Repaglinide D5 is deuterium labeled Repaglinide. Repaglinide is an insulin secretagogue for treatment type-2 diabetes mellitus. | |||
T11416 | Glucagon receptor antagonists-5 | Others | Others |
Glucagon receptor antagonists-5 is an orally bioavailable indazole-based glucagon receptor antagonist (Ki: 32 nM). It has potential for the treatment of type 2 diabetes mellitus (T2DM). | |||
T61875 | Rivoglitazone | ||
Rivoglitazone 是一种噻唑烷二酮衍生物,PPARγ的激动剂,用于治疗2型糖尿病。 | |||
T26718 |
AZD6370
AZD-6370,AZD 6370 |
||
AZD-6370 is a glucokinase activator. AZD-6370 decreases fasting and postprandial glucose in type 2 diabetes mellitus patients with effects influenced by dosing regimen and food. AZD-6370 do not affect the central counterregulatory response to hypoglycemia | |||
T13022L |
SSTR5 antagonist 2 TFA
|
Others | Others |
SSTR5 antagonist 2 TFA is a highly potent, oral active and selective antagonist of somatostatin (receptor) subtype 5 (SSTR5), with potential to treat type 2 diabetes mellitus (T2DM). | |||
T35265 |
YM-440
YM440,YM 440 |
||
YM-440 is a novel hypoglycemic agent, an insulin sensitizer, that may be used for the treatment of type 2 diabetes mellitus by reducing glucose 6-phosphatase activity in obese Zucker rats and inhibiting liver glucose output through gluconeogenesis. | |||
T11730 | JTT 551 | Others | Others |
JTT 551 can be used in the research of type 2 diabetes mellitus. JTT 551 is selective a protein tyrosine phosphatase 1B (PTP1B) inhibitor, with Kis of 0.22 μM and 9.3 μM for PTP1B and TCPTP (T-cell protein tyrosine phosphatase), respectively. | |||
T38539 |
Luseogliflozin hydrate
鲁格列净水合物,TS 071 hydrate |
||
Luseogliflozin (TS 071) hydrate, a second-generation sodium-glucose co-transporter 2 (SGLT2) inhibitor, exhibits selective potency and oral activity, with an IC50 of 2.26 nM. This compound is utilized in research for the treatment of type 2 diabetes mellitus (T2DM). | |||
TP1340 |
Lixisenatide
|
||
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).It is an injectable diabetes medicine that helps control blood sugar levels. | |||
T68000 |
MK 0533
|
||
Mk-0533是一种选择性过氧化物酶体增殖激活受体γ调节剂,用于治疗2型糖尿病。 | |||
T68976 | Piragliatin | ||
Piragliatin, also known as RO4389620, is a glucokinase activator. Piragliatin greatly enhances glucose-induced pancreatic islet respiration and insulin release. Piragliatin lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus. Piragliatin has an acute glucose-lowering action in patients with mild type 2 diabetes, mainly mediated through a generalized enhancement of β-cell function and through fasting restricted changes in ... | |||
T40349 |
DS45500853
|
||
DS45500853, an estrogen-related receptor α (ERRα) agonist, acts as an inhibitor of the binding interaction between receptor-interacting protein 140 (RIP140) corepressor peptide (10 nM) and GST-ERRα ligand-binding domain (LBD; 1.2 μM), exhibiting an IC50 of 0.80 μM. This compound holds potential for research pertaining to metabolic disorders, particularly type 2 diabetes mellitus (T2DM). | |||
T78731 |
α-Glucosidase-IN-26
|
Glucosidase | Metabolism |
α-Glucosidase-IN-26(化合物 7i)是一种有效的α-glucosidase抑制剂,其半抑制浓度(IC50)为4.63 µM,适用于2型糖尿病(T2DM)的研究。 | |||
T60294 | FBPase-IN-2 | ||
FBPase-IN-2 (HS36) 是一种有效的果糖-1,6-二磷酸酶 (FBPase) 共价抑制剂,IC50值为 0.15 μM。FBPase-IN-2 可减少肝细胞内葡萄糖的产生,可用于二型糖尿病的研究。 | |||
T62985 |
Cofrogliptin
|
||
Cofrogliptin (HSK7653) (compound 2) 是一种四氢吡喃衍生物,是一种口服具有活力的 DPP-4 抑制剂,具有长效降糖作用。Cofrogliptin (compound 2) 具有潜力进行 2 型糖尿病 (T2DM) 的研究。 | |||
T78313 |
Fazpilodemab
BFKB8488A |
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Fazpilodemab (BFKB8488A) 是靶向 FGFR1c 和 Klothoβ 的激动性人源化双特异性抗体,适用于T2DM或NAFLD的研究。 | |||
T73875 |
Fotagliptin benzoate
|
||
Fotagliptin benzoate,作为一种二肽基肽酶IV (DPP-4) 抑制剂(IC50=2.27 nM),在大鼠和狗中展现了安全性,适用于2型糖尿病的研究。 | |||
T69953 |
MK-8666 Tris
|
||
MK-8666 Tris is a partial GPCR (G-protein-coupled receptor) agonist that is coordinated with the action of GPR40. GPR40, also known as free fatty acid (FFA) receptor 1 modulates fatty acid-induced insulin secretion in pancreatic beta cells and in intestinal enteroendocrine cells. Thus, MK-8666 Tris has been investigated for treatment of type 2 diabetes mellitus and has been shown to robustly lower glucose without negative effects. | |||
T62572 |
Enclomiphene hydrochloride
|
||
Enclomiphene ((E)-Clomiphene) hydrochloride 是一种口服具有活力的、有效的非甾体雌激素受体 (estrogen receptor) 拮抗剂,具有抗雌激素作用。Enclomiphene hydrochloride 能够用于研究卵巢功能障碍、睾酮缺乏、男性性腺功能减退症和 type 2 型糖尿病。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7846 |
Aegeline
|
Others; Antifungal | Microbiology/Virology; Others |
Aegeline 是从 Aegle marmelos 的叶子中分离出来的一种生物碱酰胺,有抗高血糖和抗血脂异常的活性。 | |||
T1273 |
Diacerein
双醋瑞因,Diacerhein,Fisiodar,Diacetylrhein |
IL Receptor; Interleukin | Immunology/Inflammation |
Diacerein (Fisiodar) 是一种慢效具有白介素-1β 抑制效果的蒽醌类化合物。 | |||
T0461L |
Berberine sulfate
AI3-61947,Berberin sulfate,Berberine sulphate,Berberal |
||
Berberine sulfate (Berberal) 是苄基异喹啉生物碱原小檗碱类的季铵盐,可用于研究2型糖尿病、腹部肥胖和代谢相关脂肪性肝病。 | |||
T5S0384 |
Rhapontin
Ponticin,土大黄苷,Rhaponiticin,Rhaponticin,Rhapontigenin glucoside |
Apoptosis; Others | Apoptosis; Others |
Rhapontin (Ponticin) 是药用大黄的一种成分,可减轻KK/Ay 糖尿病小鼠肝脏脂肪变性,改善血糖和血脂,表明其具有显着的降糖作用,有望成为治疗2型糖尿病及其并发症的新药。 | |||
T3S1612 |
kuwanon G
桑黄酮G,Moracenin B,桑黄酮 G,Kuwanone G |
Phosphatase; Antibacterial; Bombesin Receptor; AChR; AChE; Glucosidase | GPCR/G Protein; Metabolism; Microbiology/Virology; Neuroscience |
Kuwanon G (Moracenin B) 是一种从桑树中得到的黄酮类蛙皮素受体拮抗剂,具有杀菌作用。 | |||
T8274 |
3-Methyl-L-histidine
|
Endogenous Metabolite | Metabolism |
3-Methyl-L-histidine 是一种肉类尤其是鸡肉摄入和大豆制品摄入的生物标记。 | |||
TN5119 | Taxoquinone | Tyrosinase; Antifection | Microbiology/Virology; Proteases/Proteasome |
Taxoquinone has strong antibacterial effect, it could be used as a promising antibacterial agent in food industry to inhibit the growth of certain important foodborne pathogens. It (100 ug/disc) displays potential anticandidal effect against Candia albica |